Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

1.3K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.3K
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

467
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
467
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

520
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
520
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

884
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
884
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

801
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
801

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Imagining Genomics and Population Health in 2050: Anticipating Future Research, Policy, and Governance Needs.

Public health genomics·2026
Same author

Project ODIN: advancing environmental genomic surveillance for public health across sub-Saharan Africa.

The Lancet. Microbe·2026
Same author

Global approaches to infectious disease surveillance and modeling.

Nature medicine·2026
Same author

Mapping pathogen genomics training provision: a structured analysis within a global consortium network.

Frontiers in public health·2026
Same author

Multi-trait GWAS reveals divergent local and polygenic architecture of cardiovascular traits across African and European ancestries in the UK Biobank.

Communications biology·2026
Same author

Unleashing potential: assessing Africa's readiness for the data science revolution to impact health.

Nature communications·2026
Same journal

Heterogeneity of plasmids containing OXA-48-like and NDM-5 carbapenemases and emergence of OXA-181 and NDM-5 co-carrying strains and plasmids in Escherichia coli from veterinary settings.

Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases·2026
Same journal

Projected late-century climate change alters reproductive gene expression pathways in the arbovirus vector Aedes aegypti.

Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases·2026
Same journal

Diseases of the past were not our diseases: Rethinking retrospective diagnosis in medicine.

Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases·2026
Same journal

Genomic insights into Listeria monocytogenes isolates associated with neurological forms.

Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases·2026
Same journal

Optimal control and cost-effectiveness analysis of a network-inspired multihost fascioliasis model.

Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases·2026
Same journal

Genomic surveillance and molecular evolution of SARS-CoV-2 in Zhangzhou, China (2022-2025).

Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases·2026
See all related articles

Related Experiment Videos

Understanding TB latency using computational and dynamic modelling procedures.

Gesham Magombedze1, Nicola Mulder

  • 1National Institute for Mathematical and Biological Synthesis, 1534 White Ave., University of Tennessee, Knoxville, TN 37996-1527, USA. gmagombedze@nimbios.org

Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases
|November 14, 2012
PubMed
Summary
This summary is machine-generated.

Mycobacterium tuberculosis adapts to host environments, causing latent infections. Systems biology and mathematical modeling identified key genes in TB latency, offering potential new drug targets for tuberculosis treatment.

Related Experiment Videos

Area of Science:

  • Microbiology
  • Systems Biology
  • Bioinformatics

Background:

  • Mycobacterium tuberculosis (TB) causes persistent latent infections unresponsive to current drugs.
  • Bacilli's survival relies on adapting to intracellular environments and evading host defenses.

Purpose of the Study:

  • To enhance understanding of TB latency dynamics using bioinformatics and mathematical modeling.
  • To identify key regulatory genes and networks involved in TB bacilli survival during latency.

Main Methods:

  • Analysis of time-course microarray gene expression data under simulated hypoxia.
  • Reverse network engineering to predict gene dependencies and regulatory interactions.
  • Biochemical Systems Theory for mathematical modeling of gene regulatory networks.

Main Results:

  • Determined gene profiles for bacilli adaptation and survival in latency.
  • Identified significant regulatory genes crucial for TB latency.
  • Predicted functions of latency genes by analyzing gene clusters in stationary and non-replicating phases.

Conclusions:

  • The study predicted key genes in the TB latency/dormancy program as potential drug targets.
  • A systems biology approach combined with computational experiments identified novel therapeutic targets.
  • Experimental validation is required for the identified gene candidates.